HEADER OXIDOREDUCTASE 02-DEC-04 1Y5R TITLE THE CRYSTAL STRUCTURE OF MURINE 11B-HYDROXYSTEROID DEHYDROGENASE TITLE 2 COMPLEXED WITH CORTICOSTERONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE, ISOZYME 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 11-DH, 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1, 11-BETA-HSD1, COMPND 5 11BETA- HSD1A; COMPND 6 EC: 1.1.1.146; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: HSD11B1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: GM221; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PAMG21 KEYWDS CORTICOSTERONE BOUND, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.ZHANG,T.D.OSSLUND,M.H.PLANT,C.L.CLOGSTON,R.E.NYBO,F.XIONG, AUTHOR 2 J.M.DELANEY,S.JORDAN REVDAT 3 14-FEB-24 1Y5R 1 REMARK SEQADV REVDAT 2 24-FEB-09 1Y5R 1 VERSN REVDAT 1 17-MAY-05 1Y5R 0 JRNL AUTH J.ZHANG,T.D.OSSLUND,M.H.PLANT,C.L.CLOGSTON,R.E.NYBO,F.XIONG, JRNL AUTH 2 J.M.DELANEY,S.JORDAN JRNL TITL CRYSTAL STRUCTURE OF MURINE 11-HYDROXYSTEROID DEHYDROGENASE JRNL TITL 2 1: AN IMPORTANT THERAPEUTIC TARGET FOR DIABETES JRNL REF BIOCHEMISTRY V. 44 6948 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 15865440 JRNL DOI 10.1021/BI047599Q REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 20924 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM OF 8% REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1692 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4078 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.07800 REMARK 3 B22 (A**2) : 7.07800 REMARK 3 B33 (A**2) : -14.15500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.763 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.301 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.262 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.916 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.053 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : N12.XPRM REMARK 3 PARAMETER FILE 5 : CORTAB.XPRM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Y5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1000031150. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21330 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8M LI2SO4, 0.1M HEPES, PH 7.5, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 109.26100 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.63050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 163.89150 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 109.26100 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 163.89150 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 54.63050 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -137.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 96.05100 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 96.05100 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 54.63050 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 ASN A 24 REMARK 465 VAL A 290 REMARK 465 SER A 291 REMARK 465 ASN A 292 REMARK 465 MET B 17 REMARK 465 HIS B 18 REMARK 465 HIS B 19 REMARK 465 HIS B 20 REMARK 465 HIS B 21 REMARK 465 HIS B 22 REMARK 465 HIS B 23 REMARK 465 ASN B 24 REMARK 465 VAL B 290 REMARK 465 SER B 291 REMARK 465 ASN B 292 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN A 123 CB - CG - CD ANGL. DEV. = 22.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 29 -17.28 -41.32 REMARK 500 MET A 31 -8.83 -57.71 REMARK 500 ALA A 65 -158.89 -179.09 REMARK 500 HIS A 130 -78.72 -121.56 REMARK 500 ASP A 131 22.16 -155.92 REMARK 500 SER A 169 -163.60 -115.69 REMARK 500 ALA A 172 14.15 -69.10 REMARK 500 MET A 179 13.24 82.24 REMARK 500 ILE A 180 38.51 -144.23 REMARK 500 ASP A 219 45.75 -65.06 REMARK 500 ILE A 230 -44.95 -130.05 REMARK 500 ALA A 233 138.04 -31.09 REMARK 500 ASN A 270 72.96 44.69 REMARK 500 ARG A 282 21.67 -65.50 REMARK 500 LYS A 286 -14.29 -41.35 REMARK 500 PRO B 29 -7.87 -52.99 REMARK 500 LYS B 44 -46.49 -142.37 REMARK 500 ALA B 65 -158.52 178.07 REMARK 500 SER B 67 99.73 -69.75 REMARK 500 ALA B 86 108.83 -164.61 REMARK 500 SER B 127 138.78 -176.78 REMARK 500 HIS B 130 -70.61 -124.77 REMARK 500 ASP B 131 26.15 -163.20 REMARK 500 PHE B 144 -59.00 -120.10 REMARK 500 SER B 164 149.81 -172.31 REMARK 500 ALA B 172 8.21 -69.93 REMARK 500 ILE B 180 37.87 -145.01 REMARK 500 ASP B 219 -12.53 -48.31 REMARK 500 THR B 220 153.69 -49.82 REMARK 500 ASN B 270 65.17 37.75 REMARK 500 MET B 288 -7.22 -55.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C0R A 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE C0R B 12 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Y5M RELATED DB: PDB REMARK 900 THE PROTEIN WITH A DETERGENT MOLECULE BOUND IN THE STEROID BINDING REMARK 900 POCKET DBREF 1Y5R A 24 292 UNP P50172 DHI1_MOUSE 22 290 DBREF 1Y5R B 24 292 UNP P50172 DHI1_MOUSE 22 290 SEQADV 1Y5R MET A 17 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 18 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 19 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 20 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 21 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 22 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS A 23 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R MET B 17 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 18 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 19 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 20 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 21 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 22 UNP P50172 CLONING ARTIFACT SEQADV 1Y5R HIS B 23 UNP P50172 CLONING ARTIFACT SEQRES 1 A 276 MET HIS HIS HIS HIS HIS HIS ASN GLU GLU PHE ARG PRO SEQRES 2 A 276 GLU MET LEU GLN GLY LYS LYS VAL ILE VAL THR GLY ALA SEQRES 3 A 276 SER LYS GLY ILE GLY ARG GLU MET ALA TYR HIS LEU SER SEQRES 4 A 276 LYS MET GLY ALA HIS VAL VAL LEU THR ALA ARG SER GLU SEQRES 5 A 276 GLU GLY LEU GLN LYS VAL VAL SER ARG CYS LEU GLU LEU SEQRES 6 A 276 GLY ALA ALA SER ALA HIS TYR ILE ALA GLY THR MET GLU SEQRES 7 A 276 ASP MET THR PHE ALA GLU GLN PHE ILE VAL LYS ALA GLY SEQRES 8 A 276 LYS LEU MET GLY GLY LEU ASP MET LEU ILE LEU ASN HIS SEQRES 9 A 276 ILE THR GLN THR SER LEU SER LEU PHE HIS ASP ASP ILE SEQRES 10 A 276 HIS SER VAL ARG ARG VAL MET GLU VAL ASN PHE LEU SER SEQRES 11 A 276 TYR VAL VAL MET SER THR ALA ALA LEU PRO MET LEU LYS SEQRES 12 A 276 GLN SER ASN GLY SER ILE ALA VAL ILE SER SER LEU ALA SEQRES 13 A 276 GLY LYS MET THR GLN PRO MET ILE ALA PRO TYR SER ALA SEQRES 14 A 276 SER LYS PHE ALA LEU ASP GLY PHE PHE SER THR ILE ARG SEQRES 15 A 276 THR GLU LEU TYR ILE THR LYS VAL ASN VAL SER ILE THR SEQRES 16 A 276 LEU CYS VAL LEU GLY LEU ILE ASP THR GLU THR ALA MET SEQRES 17 A 276 LYS GLU ILE SER GLY ILE ILE ASN ALA GLN ALA SER PRO SEQRES 18 A 276 LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS GLY THR ALA SEQRES 19 A 276 LEU ARG LYS SER GLU VAL TYR TYR ASP LYS SER PRO LEU SEQRES 20 A 276 THR PRO ILE LEU LEU GLY ASN PRO GLY ARG LYS ILE MET SEQRES 21 A 276 GLU PHE PHE SER LEU ARG TYR TYR ASN LYS ASP MET PHE SEQRES 22 A 276 VAL SER ASN SEQRES 1 B 276 MET HIS HIS HIS HIS HIS HIS ASN GLU GLU PHE ARG PRO SEQRES 2 B 276 GLU MET LEU GLN GLY LYS LYS VAL ILE VAL THR GLY ALA SEQRES 3 B 276 SER LYS GLY ILE GLY ARG GLU MET ALA TYR HIS LEU SER SEQRES 4 B 276 LYS MET GLY ALA HIS VAL VAL LEU THR ALA ARG SER GLU SEQRES 5 B 276 GLU GLY LEU GLN LYS VAL VAL SER ARG CYS LEU GLU LEU SEQRES 6 B 276 GLY ALA ALA SER ALA HIS TYR ILE ALA GLY THR MET GLU SEQRES 7 B 276 ASP MET THR PHE ALA GLU GLN PHE ILE VAL LYS ALA GLY SEQRES 8 B 276 LYS LEU MET GLY GLY LEU ASP MET LEU ILE LEU ASN HIS SEQRES 9 B 276 ILE THR GLN THR SER LEU SER LEU PHE HIS ASP ASP ILE SEQRES 10 B 276 HIS SER VAL ARG ARG VAL MET GLU VAL ASN PHE LEU SER SEQRES 11 B 276 TYR VAL VAL MET SER THR ALA ALA LEU PRO MET LEU LYS SEQRES 12 B 276 GLN SER ASN GLY SER ILE ALA VAL ILE SER SER LEU ALA SEQRES 13 B 276 GLY LYS MET THR GLN PRO MET ILE ALA PRO TYR SER ALA SEQRES 14 B 276 SER LYS PHE ALA LEU ASP GLY PHE PHE SER THR ILE ARG SEQRES 15 B 276 THR GLU LEU TYR ILE THR LYS VAL ASN VAL SER ILE THR SEQRES 16 B 276 LEU CYS VAL LEU GLY LEU ILE ASP THR GLU THR ALA MET SEQRES 17 B 276 LYS GLU ILE SER GLY ILE ILE ASN ALA GLN ALA SER PRO SEQRES 18 B 276 LYS GLU GLU CYS ALA LEU GLU ILE ILE LYS GLY THR ALA SEQRES 19 B 276 LEU ARG LYS SER GLU VAL TYR TYR ASP LYS SER PRO LEU SEQRES 20 B 276 THR PRO ILE LEU LEU GLY ASN PRO GLY ARG LYS ILE MET SEQRES 21 B 276 GLU PHE PHE SER LEU ARG TYR TYR ASN LYS ASP MET PHE SEQRES 22 B 276 VAL SER ASN HET NDP A 1 73 HET C0R A 11 25 HET NDP B 2 73 HET C0R B 12 25 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM C0R CORTICOSTERONE HETSYN C0R (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 C0R 2(C21 H30 O4) HELIX 1 1 ARG A 28 GLN A 33 5 6 HELIX 2 2 LYS A 44 LYS A 56 1 13 HELIX 3 3 SER A 67 LEU A 81 1 15 HELIX 4 4 ASP A 95 GLY A 111 1 17 HELIX 5 5 ASP A 132 PHE A 144 1 13 HELIX 6 6 PHE A 144 ASN A 162 1 19 HELIX 7 7 ALA A 172 LYS A 174 5 3 HELIX 8 8 ILE A 180 THR A 204 1 25 HELIX 9 9 THR A 220 SER A 228 1 9 HELIX 10 10 PRO A 237 LEU A 251 1 15 HELIX 11 11 LEU A 263 GLY A 269 1 7 HELIX 12 12 ASN A 270 ARG A 282 1 13 HELIX 13 13 TYR A 283 TYR A 284 5 2 HELIX 14 14 ASN A 285 PHE A 289 5 5 HELIX 15 15 ARG B 28 LEU B 32 5 5 HELIX 16 16 GLY B 45 MET B 57 1 13 HELIX 17 17 SER B 67 GLY B 82 1 16 HELIX 18 18 ASP B 95 GLY B 111 1 17 HELIX 19 19 ASP B 132 PHE B 144 1 13 HELIX 20 20 PHE B 144 ASN B 162 1 19 HELIX 21 21 ALA B 172 LYS B 174 5 3 HELIX 22 22 ILE B 180 THR B 204 1 25 HELIX 23 23 THR B 220 ILE B 227 1 8 HELIX 24 24 PRO B 237 LEU B 251 1 15 HELIX 25 25 LEU B 263 GLY B 269 1 7 HELIX 26 26 ASN B 270 ARG B 282 1 13 HELIX 27 27 TYR B 283 TYR B 284 5 2 HELIX 28 28 ASN B 285 PHE B 289 5 5 SHEET 1 A 7 SER A 85 TYR A 88 0 SHEET 2 A 7 HIS A 60 THR A 64 1 N LEU A 63 O HIS A 87 SHEET 3 A 7 LYS A 36 THR A 40 1 N VAL A 37 O HIS A 60 SHEET 4 A 7 MET A 115 LEU A 118 1 O MET A 115 N ILE A 38 SHEET 5 A 7 SER A 164 SER A 170 1 O ALA A 166 N LEU A 116 SHEET 6 A 7 SER A 209 LEU A 215 1 O SER A 209 N ILE A 165 SHEET 7 A 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 B 7 SER B 85 ALA B 90 0 SHEET 2 B 7 HIS B 60 ALA B 65 1 N LEU B 63 O HIS B 87 SHEET 3 B 7 LYS B 36 VAL B 39 1 N VAL B 37 O HIS B 60 SHEET 4 B 7 MET B 115 LEU B 118 1 O MET B 115 N ILE B 38 SHEET 5 B 7 SER B 164 SER B 170 1 O ALA B 166 N LEU B 116 SHEET 6 B 7 SER B 209 LEU B 215 1 O SER B 209 N ILE B 165 SHEET 7 B 7 GLU B 255 TYR B 258 1 O TYR B 258 N VAL B 214 SITE 1 AC1 25 C0R A 11 GLY A 41 SER A 43 LYS A 44 SITE 2 AC1 25 GLY A 45 ILE A 46 ALA A 65 ARG A 66 SITE 3 AC1 25 SER A 67 THR A 92 MET A 93 ASN A 119 SITE 4 AC1 25 ILE A 121 ILE A 168 SER A 169 SER A 170 SITE 5 AC1 25 TYR A 183 LYS A 187 LEU A 215 GLY A 216 SITE 6 AC1 25 LEU A 217 ILE A 218 THR A 220 THR A 222 SITE 7 AC1 25 ALA A 223 SITE 1 AC2 25 C0R B 12 GLY B 41 SER B 43 LYS B 44 SITE 2 AC2 25 GLY B 45 ILE B 46 ARG B 66 SER B 67 SITE 3 AC2 25 THR B 92 MET B 93 ASN B 119 HIS B 120 SITE 4 AC2 25 ILE B 121 ILE B 168 SER B 169 SER B 170 SITE 5 AC2 25 TYR B 183 LYS B 187 LEU B 215 GLY B 216 SITE 6 AC2 25 LEU B 217 ILE B 218 THR B 220 THR B 222 SITE 7 AC2 25 ALA B 223 SITE 1 AC3 6 NDP A 1 ILE A 121 SER A 170 GLN A 177 SITE 2 AC3 6 TYR A 183 THR A 222 SITE 1 AC4 9 NDP B 2 ILE B 121 THR B 124 SER B 170 SITE 2 AC4 9 GLN B 177 ILE B 180 TYR B 183 LEU B 217 SITE 3 AC4 9 ILE B 227 CRYST1 96.051 96.051 218.522 90.00 90.00 90.00 P 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010411 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010411 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004576 0.00000